Royalty Pharma buys partial royalty interest on Prevymis from AiCuris Anti-infective Cures GmbH
Royalty Pharma has acquired a partial royalty interest on Prevymis™[1] (letermovir) from AiCuris for a one-time-payment of $220 million.
Pharmaceuticals, Biotechnology and Life Sciences
Royalty Pharma has acquired a partial royalty interest on Prevymis™[1] (letermovir) from AiCuris for a one-time-payment of $220 million.
Packaging Technology Group, Inc., (PTG), a leading provider of thermal packaging solutions for the biopharmaceutical and life sciences sector, has opened a new location in Louisville, Kentucky.
SOMERSET, N.J.–(BUSINESS WIRE)–Legend Biotech (NASDAQ: LEGN) announced today that it has appointed Dr. Corazon (Corsee) Dating Sanders, Dr. Darren Ji,…
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Phase…
– BT051 IND Clearance – Phase 1 Clinical Trial Initiation CONCORD, Mass.–(BUSINESS WIRE)–Bacainn Therapeutics, Inc., a Company developing novel therapies…
LONDON–(BUSINESS WIRE)–#CompetitiveIntelligence–Infiniti Research is the world’s leading independent provider of strategic market intelligence solutions. Our market intelligence services are designed…
– Funds to be Used for Manufacturing Capacity Expansion of Commercially Available Testing Kit and to Support Pathway to Production…
TORONTO–(BUSINESS WIRE)–#FSDDF—FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (the “Company”) announces the closing of a previously announced private…
Bayer Animal Health will distribute and market selected products from Bioiberica´s Companion Animal Health portfolio in eight countries The selected…
LONDON–(BUSINESS WIRE)–#Analytics–Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems brings…